Title of article
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
Author/Authors
Miriam Koopman، نويسنده , , Ninja F Antonini، نويسنده , , Joep Douma، نويسنده , , Jaap Wals، نويسنده , , Aafke H Honkoop، نويسنده , , Frans LG Erdkamp، نويسنده , , Robert M. de Jong، نويسنده , , Cees J Rodenburg، نويسنده , , Gerard Vreugdenhil، نويسنده , , Olaf JL Loosveld، نويسنده , , Aart van Bochove، نويسنده , , Harm AM Sinnige، نويسنده , , Geert-Jan M Creemers، نويسنده , , Margot ET Tesselaar، نويسنده , , Peter H Th ، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
8
From page
135
To page
142
Abstract
Background
The optimum use of cytotoxic drugs for advanced colorectal cancer has not been defined. Our aim was to investigate whether combination treatment is better than sequential administration of the same drugs in patients with advanced colorectal can
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
591623
Link To Document